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ABSTRACT 
Purpose: To document the long-term outcome of Brånemark implants installed in augmented 
maxillary bone and to identify parameters which are associated with peri-implant bone level. 
Material and methods: Patients of a periodontal practice who had been referred to a maxillofacial 
surgeon for iliac crest bone grafting in the atrophic maxilla were retrospectively recruited. Five months 
following grafting they received 7 to 8 turned Brånemark implants. Following submerged healing of 
another 5 months, implants were uncovered and restorative procedures for fixed rehabilitation were 
initiated 2 to 3 months thereafter. The primary outcome variable was bone level defined as the distance 
from the implant-abutment interface to the first visible bone-to-implant contact. Secondary outcome 
variables included plaque index, bleeding index, probing depth and levels of 40 species in subgingival 
plaque samples as identified by means of checkerboard DNA-DNA hybridization. 
Results: Nine out of 16 patients (8 females, 1 male; mean age 59) with 71 implants agreed to come in 
for evaluation after on average 9 years (SD 4; range 3 – 13) of function. One implant was deemed 
mobile at the time of inspection. Clinical conditions were acceptable with 11 % of the implants 
showing pockets ≥ 5 mm. Periodontopathogens were frequently and in high numbers encountered. 
Clinical parameters and bacterial levels were highly patient-dependent. The mean bone level was 2.30 
mm (SD 1.53; range 0.00 – 6.95) with 23 % of the implants demonstrating advanced resorption (bone 
level > 3 mm). Regression analysis showed a significant association of the patient (p < 0.001) and 
plaque index (p = 0.007) with bone level. 
Conclusions: The long-term outcome of Brånemark implants installed in iliac crest augmented 
maxillary bone is acceptable, however advanced peri-implant bone loss is rather common and 
indicative of graft resorption. This phenomenon is patient-dependent and seems also associated with 
oral hygiene. 
Introduction 
Implant treatment is a common and straightforward procedure in most patients. However, bone 
resorption secondary to periodontal disease, tooth loss or ill-fitting prostheses may lead to severe 
atrophy (1), requiring reconstructive surgery prior to implant placement. Several procedures using 
inlay and onlay techniques have been described. The former include Le Fort I osteotomy with 
interpositional bone grafting and sinus augmentation (2, 3). Onlay techniques are used for horizontal 
ridge augmentation usually using autogenous bone blocks. If limited bone gain is needed the chin or 
retromolar region may serve as suitable donor sites. Large volumes require extra-oral donor sites such 
as the iliac crest or calvarium. 
An important concern following all bone augmentation procedures is volume stability of the graft. 
Even though no augmentation technique has detailed documentation or long-term follow-up studies as 
described in a recent systematic review (4), graft resorption seems inevitable (5). Bone blocks from 
intra-oral donor sites may lose up to 50 to 60 % of their volume after one year (6, 7). When applied as 
an onlay graft, also bone blocks from the iliac crest have shown considerable resorption of nearly half 
of their volume after 1 year (8). 
Another issue relates to the survival and bone remodelling of dental implants installed in augmented 
bone. Implant survival rates of about 75 % have been reported for turned titanium implants placed in 
the iliac crest augmented maxilla after 3 to 5 years of function (9, 10). Although a recent long-term 
study described higher survival rates (11), these findings suggest that turned titanium implants could 
be more prone to failure when installed in augmented maxillary bone. Limited data exist on bone 
adaptation around turned titanium implants installed in the iliac crest augmented maxilla. Adell and 
co-workers (9) described a mean bone level of 1.49 mm in reference to the implant-abutment interface 
after one year and about 0.10 mm annually thereafter. This corresponds quite well with recent findings 
by Nyström et al. (11) pointing to a mean bone level of 2.40 mm after 10 years of function. Still, 
frequency distributions and microbiological data have never been described and no attempt has been 
made so far to identify parameters which are associated with bone level under these conditions. 
Hence, the primary goal of this study was to evaluate the long-term overall outcome of turned titanium 
implants installed in iliac crest augmented maxillary bone. A secondary objective was to identify 
parameters which are associated with peri-implant bone level. 
 
Material and methods 
Patient selection 
Patients of a periodontal practice were retrospectively recruited for a cross-sectional evaluation based 
on the following inclusion criteria: 
1.       All had been referred to a maxillofacial centre (AZ Sint-Jan, Bruges, Belgium) for advanced 
bone augmentation in the fully-edentulous atrophic maxilla 
2.       Bone augmentation was performed by one and the same experienced maxillofacial surgeon 
(CDC) 
3.       Bone augmentation included onlay grafting using iliac crest bone blocks in combination with 
sinus augmentation if necessary 
4.       Implant surgery was performed by two experienced periodontists (HDB, BC) using turned 
Brånemark implants (Nobel Biocare, Göteborg, Sweden) 
5.       Implants were restored with a full-arch bridge 
The study was conducted in accordance with the Helsinki declaration of 1975 as revised in 2000 and 
the protocol was approved by the ethical committee of the University Hospital in Ghent (UZ Gent). 
 
Surgical procedures 
Reconstructive surgery was performed under general anaesthesia with oral endotracheal intubation. A 
small incision was made at the spina iliaca anterior superior making access to the iliac crest. 
Monocortical bone blocks and cancellous bone were harvested (fig. 1). Thereafter, the wound was 
closed in layers.  Intra-orally, a crestal incision was made to raise a mucoperiosteal flapexposing the 
alveolar process and lateral sinus walls if necessary. The cortical iliac bone blocks were used as saddle 
or veneer onlay grafts at the buccal side of the atrophic ridge and fixed with small titanium screws. If 
necessary, sinus augmentation was performed with cancellous bone as filling material. In order to 
avoid tension on the flap, a horizontal periosteal incision was made. Closure of the flap was achieved 
by means of single sutures. All patients were discharged from the hospital after a few days and were 
not allowed to wear removable prostheses for at least 1 month. 
After a healing period of 5 months patients were sent back to the referring practice for implant surgery 
under local anaesthesia. A full-arch mucoperiosteal flap was raised following crestal incision and all 
fixation screws were removed. Seven to 8 turned Brånemark implants (Nobel Biocare, Göteborg, 
Sweden) were placed subcrestally to reduce the risk for perforation as a result of graft resorption. 
Following submerged healing of another 5 months, implants were uncovered and healing abutments 
were installed. The general dentist initiated the restorative procedure for fixed rehabilitation 2 to 3 
months thereafter. 
 
(HERE APPROXIMATELY FIGURE 1 PLEASE) 
 
Clinical evaluation 
All patients were examined by one and the same trained clinician who had not been involved in the 
treatment (SV). Plaque and bleeding index were recorded at six sites per implant (mesial, central, 
distal; buccally as well as orally). Both included a score ranging from 0 to 3 (12). Following removal 
of the bridge, probing depth was measured to the nearest 0.5 mm using a manual periodontal probe 
(CP 15 UNC, Hu-Friedy
®
, Chicago, USA) at the same six sites. Removal of the bridge also allowed 
for evaluation of implant mobility. Patient’s records were scrutinized for implant failure that had 
occurred in the past. 
 
Microbiological evaluation 
Subgingival microbial samples were obtained from the deepest pocket of each implant just prior to 
removal of the bridge. Supragingival plaque was removed with sterile cotton pellets, and a sterile 
paper point (Mynol Plus, Ada Products, Milwaukee, WI) was then inserted into the pocket until 
resistance was felt. After leaving it in situ for 20 s, each paper point was placed in a separate sterile 
and dry Eppendorftube. All samples were immediately stored at –20°C in Ghent and mailed to the 
processing centre in Berne within 30 days. There, microbiological analysis was performed using the 
checkerboard DNA-DNA hybridization technique. This assay included a panel of 40 bacterial species. 
Details of the procedures have been described elsewhere (13-16). Briefly, the samples were 
individually placed in Eppendorf tubes containing 0.15 ml TE (10 mM Tris-HCL, 1 mM EDTA, pH 
7.6). Within 30 min, 0.1 ml 5 M NaOH was added to each tube. Bacterial DNA was extracted, 
concentrated on nylon membranes (Roche Diagnostics GmbH, Mannheim, Germany) and fixed by 
cross-linking using ultraviolet light (Stratalinker 1800, Stratagene, La Jolla, CA). The membranes with 
fixed DNA were placed in a Miniblotter 45 (Immunetics, Cambridge MA). A 30 x 45 ‘checkerboard’ 
pattern was produced as described by Socransky et al. (13) and Katsoulis et al. (14). 
Chemiluminescent signals were detected using the Storm Fluor-Imager (Storm 840, Amersham 
Biosciences, Piscataway NJ, USA). In order to receive a full detailed account of the identified bacteria, 
the digitized information was analyzed by a software program (ImageQuant, Amersham Pharmacia, 
Piscataway NJ), allowing comparison of signals against standard lanes of known bacterial amounts. 
Signals were converted to absolute counts by comparison with these standards and studied as the 
proportion of sites defined as having > 1 x 10
4
 bacterial cells. The outcome variables for all 40 species 
were detection frequency and bacterial level. 
 
Radiographic evaluation 
A digital peri-apical radiograph was taken of each implant with the long-cone paralleling technique 
and an X-ray holder (XCP Bite Block, Dentsply Rinn, Elgin, IL, USA) with the implant bridge in 
place to enhance stability of the holder. The radiographic evaluation of the peri-implant bone level was 
done using Vixquick software (Amsterdam, the Netherlands) with an accuracy of 0.1 mm. The bone 
level was considered the primary outcome variable and was defined as the distance from the implant-
abutment interface to the first visible bone-to-implant contact. All radiographs were analysed twice by 
two clinicians (HDB, PB) in order to evaluate the intra- and inter-examiner reliability. The implant 
success was rated based on the criteria by Albrektsson & Isidor (17). 
 
Statistical analysis 
Mean values were calculated for all parameters on an individual implant basis and descriptive statistics 
included frequency distributions (plaque index, bleeding index, probing depth, bone level) and 
detection frequencies (microbiota). Intra-examiner and inter-examiner reliability on bone levels was 
assessed using percent agreement within 0.2 mm deviation, Pearsson correlation coefficients and the 
paired t-test. 
The impact of the patient factor on clinical parameters and bacterial levels was evaluated using the 
Kruskal-Wallis test. In order to explore the association between clinical and microbiological 
conditions, the implant with the lowest respectively highest probing depth was selected for each 
patient. Paired comparisons in terms of bacterial levels were performed using the Wilcoxon signed 
ranks test. 
A General Linear Model was used to examine the association of the patient, clinical parameters and 
total DNA count with bone level (dependent variable). Therefore, the patient was considered a random 
factor whereas plaque index, bleeding index, probing depth and total DNA count were included as 
covariates. A residual analysis on linearity and homoskedasticity was performed to evaluate the model 
fit. The level of significance was set at 0.05. 
 
Results 
Sixteen patients met the inclusion criteria. Four were lost to follow up. The remaining 12 were 
contacted and 9 (8 females, 1 male; mean age 59, SD 10; age range 52 – 73) agreed to come in for 
evaluation. These were all non-smokers in good general health receiving supportive care at least once 
a year. One patient had received 7 implants, the others 8 implants. The mean time in function was 9 
years (SD 4; range 3 – 13). Fifty-four out of 71 implants were in function for at least 6 years. 
 
Clinical outcome 
From the 71 implants, one presented with a buccal fistula and was found mobile when the bridge was 
removed. According to the patient’s records, there had not been any other preceding failures. 
Table 1 shows the clinical outcome in terms of plaque index, bleeding index and probing depth on 
implant level and patient level. Overall, clinical conditions were acceptable albeit high variation was 
observed. Forty-four % of the implants were plaque-free whereas 41% showed high plaque levels 
(plaque index ≥ 1). Thirty-eight % of the implants were free of inflammation as determined by the 
bleeding index whereas 10 % showed high bleeding tendency (bleeding index ≥ 1). Forty-nine % of 
the implants demonstrated shallow pockets (probing depth ≤ 3 mm) whereas 11 % showed deep 
pockets (probing depth ≥ 5 mm). Statistical analyses showed a significant impact of the patient on all 
clinical parameters (p < 0.001). 
 
(HERE APPROXIMATELY TABLE 1 PLEASE) 
 
Microbiological outcome 
Table 2 shows detection frequencies and levels of the 40 species included in the panel. Twenty-five 
out of 40 species were detected around the vast majority of the implants (detection frequency ≥ 80 %). 
In addition, 17 of these bacteria were found in high numbers (level ≥ 1 x 105). Large variation in 
bacterial levels was observed between implants. Fusobacteria, Leptotrichia buccalis, Parvimonas 
micra, Veillonella parvula and especially Tannerella forsythia showed the highest levels well 
surpassing 2 x 10
5
 bacterial counts. 
When the implant with the lowest and highest probing depth was compared on a patient level, 
implants with shallow pockets showed significantly lower counts of the following species: 
Actinomyces odontolyticus, (p = 0.048), Campylobacter gracilis (p = 0.047), Fusobacterium 
nucleatum naviforme (p = 0.039), Leptotrichia buccalis (p = 0.018). The total DNA count was not 
significantly different between implants with shallow and deep pockets (p = 0.097). 
Statistical analyses showed a significant impact of the patient on the levels of 37 out of 40 species (p ≤ 
0.024). 
 
(HERE APPROXIMATELY TABLE 2 PLEASE) 
 
Radiographic outcome 
The intra-examiner repeatability on bone levels was high (84 % agreement within 0.2 mm deviation; 
Pearsson correlation coefficient: 0.977 - p < 0.001; paired t-test: p = 0.761), as was the inter-examiner 
reproducibility (76 % agreement within 0.2 mm deviation; Pearsson correlation coefficient: 0.948 - p < 
0.001; paired t-test: p = 0.803). 
The mean bone level was 2.30 mm (SD 1.53; range 0.00 – 6.95) when analyzing data on implant level. 
A frequency distribution is given in figure 2 illustrating high variation. Forty-one % of the implants 
showed acceptable bone preservation (bone level < 2 mm) whereas 23 % demonstrated bone levels 
extending to or beyond the third implant thread (bone level > 3 mm). Based on the success criteria by 
Albrektsson & Isidor (17) 49 out of 71 (69 %) implants could be considered successful. 
When analyzing data with the patient as the experimental unit the mean bone level was 2.29 mm (SD 
1.06; range 0.10 – 3.52). Figure 3 indicates high variation within as well as between patients. 
 
(HERE APPROXIMATELY FIGURE 2 & 3 PLEASE) 
 
Parameters associated with bone level 
Table 3 shows the results of the regression analysis with bone level as the dependent variable. The 
covariates demonstrated no meaningful correlation with each other (Pearson correlation coefficient ≤ 
0.401). Hence, the data set showed no multicollinearity which is mandatory to have all parameters 
included in the analysis. The regression model was highly significant (p < 0.001) and the patient was 
most decisive for bone level (p < 0.001) followed by the oral hygiene status (plaque index; p = 0.007). 
Nor other clinical neither microbiological parameters were significant predictors for bone level (p≥ 
0.100). 63 % of the variability in the dependent variable could be explained by the regression model 
(R squared: 0.632). The model quality was satisfying given the linear relationship and 
homoskedasticity of the residuals (fig. 4). An illustration on the prediction of bone level by the 
regression model is given in figure 5. 
 
(HERE APPROXIMATELY TABLE 3 & FIGURE 4 & 5 PLEASE) 
 
Discussion 
According to the international literature the survival of dental implants installed in native bone is 
about 93 % in the long term (18, 19). Turned titanium implants installed in the augmented atrophic 
maxilla have shown lower survival rates ranging from 75 % to 90 % (9-11). In contrast, high survival 
rates surpassing 96 % have been described for surface-modified implants under comparable conditions 
(20, 21). These observations suggest that surface-modified implants may be less prone to failure than 
turned titanium implants when installed in the augmented atrophic maxilla. Interestingly, the fact that 
we only encountered one implant failure in our study may deviate from this viewpoint. However, one 
should take into account a possible oversimplification in this study having only evaluated 9 out of 16 
eligible patients. On the other hand, 3 additional patients were contacted by phone and confirmed the 
presence of all implants and the records of the remaining 4 patients did not reveal any failures up to 
their last visit. 
For this study it was decided to remove the implant bridge in all patients because of the following: 
first, it has been shown that limited access to the peri-implant sulcus is quite prevalent. This seems 
related to the prosthetic design and may compromise accurate registration in 15 % of the sites (22). 
Second, removal of the bridge enabled us to evaluate implant mobility which is considered one of the 
main criteria for success by Albrektsson & Isidor (17). 
By and large, the implants under investigation showed an acceptable clinical outcome. Still, 
periodontopathogens were frequently and in high numbers identified in the peri-implant sulcus, which 
is in accordance with previous findings based on checkerboard DNA-DNA hybridization (15, 23, 24). 
An important observation of the present study was the high variation in clinical and microbiological 
conditions of the implants, which was principally patient-related. When controlling for the patient 
factor, a significant clinical-microbiological link was only found for 4 out of 40 species. Even though 
our study was clearly not designed for this purpose, the level of significance was of marginal 
magnitude for these species and probably related to multiple testing. Indeed, when 40 independent 
tests are performed each at the 0.05 significance level, the probability that one or more will achieve 
significance by chance is 87 % (1 – 0.9540). Therefore, we believe our data may not support a link 
between clinical and microbiological peri-implant conditions within the same patient. This is in 
agreement with Renvert and co-workers (23) showing trivial difference in the microbiota between 
healthy implants and implants suffering from peri-implantitis. However, the observation that the 
patient was a highly decisive factor for the peri-implant microbial profile in this study, suggests 
apivotal impact of genetic background possibly overruling local factors. This view has never been 
addressed before, yet would reflect recent insights in periodontal disease basically showing that the 
microbial content of the periodontal pocket is determined by gene expression in the periodontal tissues 
(25). 
The primary outcome variable in this study was bone level defined as the distance from the implant-
abutment-interface to the first visible bone-to-implant contact. Mean bone level was 2.30 mm after on 
average 9 years of function, which corresponds well with long-term findings by Nyström et al. (11) on 
the same treatment concept. Frequency analysis showed that 23 % of our implants showed bone levels 
extending to or beyond the third implant thread. Even though this was not a longitudinal investigation 
including data on baseline radiographs, we believe these cases related to advanced bone loss because 
of the following. First, all implants had been inserted by two experienced implant surgeons according 
to a standard protocol of subcrestal implant placement. Second, a 3 mm bone level corresponding to 
the third implant thread clearly surpasses the measurement error of 0.8 mm (SD on the largest mean 
difference between duplicate readings multiplied by 2) for radiographic bone level analyses. 
Essentially, advanced bone loss as we frequently encountered could be the result of peri-implantitis 
and/or graft resorption. Peri-implantitis has been described as a complication of implant therapy with 
varying prevalence basically depending on the definition of the condition (26). The present sample 
only included 5 out of 71 implants (7 %) showing bone levels exceeding the physiological threshold as 
defined by Albrektsson & Isidor (17) and including clinical signs of inflammation (probing depth ≥ 5 
mm and bleeding or pus). Interestingly, only 2 of these implants showed a circular crater indicative of 
peri-implantitis and therefore, it remains debatable whether even all 5 truly qualified as peri-
implantitis cases. These findings suggest that graft resorption was the primary cause of advanced peri-
implant bone loss, which would explain why the prevalence of implant cases with extreme bone levels 
was considerably higher than reported in the study by Jemt & Johansson (27) on turned Brånemark 
implants installed in native maxillary bone and in function for 10 years (23 % versus 13 % showing 
bone level ≥ 3 mm). Hence, iliac crest grafts seem prone to resorption in the long term. Regression 
analysis showed that this was predominantly patient-related. Indeed, variability between patients was 
huge in terms of bone level ranging from 0.10 mm to 3.52 mm despite comparable reconstructive 
surgery. Bone level also varied substantially within patients, which was mainly attributed to disparities 
in plaque accumulation as shown by regression analysis. 
In contrast to iliac bone grafts, calvarium bone grafts have shown limited resorption (< 20 %) in the 
short term when used for alveolar ridge reconstruction (28). The latter seems also superior over iliac 
crest bone for sinus augmentation (29, 30). As a result and because of limited morbidity, bone grafting 
from the skull is more and more becoming part of current daily practice at the expense of iliac crest 
grafting. Given this evolution, it would be interesting to evaluate the long-term survival and bone 
adaption of implants installed in calvarium augmented maxillary bone. This would preferably be 
assessed using surface-modified implants since these have become the standard in contemporary 
implant dentistry. 
In conclusion, the long-term outcome of Brånemark implants installed in iliac crest augmented 
maxillary bone is acceptable, however advanced peri-implant bone loss is rather common and 
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